Cargando…
Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer
Programmed cell death ligand 1 (PD-L1) is a critical biomarker for predicting the response to immunotherapy. However, traditional quantitative evaluation of PD-L1 expression using immunohistochemistry staining remains challenging for pathologists. Here we developed a deep learning (DL)-based artific...
Autores principales: | Cheng, Guoping, Zhang, Fuchuang, Xing, Yishi, Hu, Xingyi, Zhang, He, Chen, Shiting, Li, Mengdao, Peng, Chaolong, Ding, Guangtai, Zhang, Dadong, Chen, Peilin, Xia, Qingxin, Wu, Meijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286729/ https://www.ncbi.nlm.nih.gov/pubmed/35844508 http://dx.doi.org/10.3389/fimmu.2022.893198 |
Ejemplares similares
-
Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer
por: Wang, Xiangyun, et al.
Publicado: (2021) -
Artificial Intelligence in Digital Pathology to Advance Cancer Immunotherapy
por: Chen, Pingjun, et al.
Publicado: (2022) -
Human Cancer Immunotherapy with PD-1/PD-L1 Blockade
por: Zheng, Peilin, et al.
Publicado: (2015) -
Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer Immunotherapy
por: Gui, Yu, et al.
Publicado: (2023) -
Applying artificial intelligence for cancer immunotherapy
por: Xu, Zhijie, et al.
Publicado: (2021)